Table 4 Serum chemistry
Parameter | Number of patients | Before treatment | After treatment | Reference range | P value | Significance |
|---|---|---|---|---|---|---|
Total bilirubin (μmol/L) | 113 | 1.13 (0.14) | 1.09 (0.15) | 0.23-1.35 | 0.002 | In normal range but significantly decreased after treatment |
Total protein (g/L) | 114 | 65.03 (5.27) | 63.20 (6.27) | 60.0-85.0 | 0.002 | In normal range but significantly decreased after treatment |
Glutamic-pyruvic transaminase, (GPT) (U/L) | 114 | 1.37 (0.22) | 1.33 (0.20) | 0.7-1.65 | 0.037 | In normal range but significantly decreased after treatment |
Glutamic-oxaloacetic transaminase (GOT) (U/L) | 114 | 23.60 (12.45) | 21.01 (8.56) | 5.0-45.0 | 0.005 | In normal range but significantly decreased after treatment |
Serum urea nitrogen (BUN) (μmol/L) | 114 | 4.63 (1.58) | 4.58 (1.88) | 2.0-7.1 | 0.750 | In normal range, no significant difference |
Serum creatinine (SCR) (μmol/L) | 114 | 1.81 (0.16) | 1.81 (0.16) | 1.64-2.12 | 0.898 | In normal range, no significant difference |
Uric acid (UA) (μmol/L) | 114 | 308.27 (80.88) | 309.28 (89.64) | 90.0-440.0 | 0.871 | In normal range, no significant difference |